Quantcast

Latest Adverse effect Stories

2014-10-20 16:27:01

Boehringer Ingelheim launches comprehensive support resources for people with idiopathic pulmonary fibrosis RIDGEFIELD, Conn., Oct. 20, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. has announced that OFEV® (nintedanib) capsules are now commercially available in the United States. OFEV was approved by the U.S. Food and Drug Administration (FDA) on October 15, 2014 for the treatment of idiopathic pulmonary fibrosis (IPF). It is the only kinase inhibitor approved to treat...

2014-10-15 20:22:42

Company to make OFEV available to IPF community within 10 days, along with comprehensive patient support resources RIDGEFIELD, Conn., Oct. 15, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved OFEV® (nintedanib) capsules for oral use for the treatment of idiopathic pulmonary fibrosis (IPF). Granted Breakthrough Therapy designation during its review by the FDA, OFEV, capsules for oral use, taken twice...

2014-09-20 12:21:10

OTTAWA, Sept. 20, 2014 /CNW/ - The issue: Mylan Pharmaceuticals ULC Canada, in consultation with Health Canada, is voluntarily recalling all lots of its Mylan-Nitro Spray 0.4 mg/metered dose due to the product missing the "dip tube," which is part of the pump component. A missing "dip tube" could pose a potential problem with the delivery of nitroglycerin to the patient. This defect may lead patients to believe they are receiving the nitroglycerin, when in fact they are unable to access it....

2014-09-18 23:13:39

Xarelto® drug takers allege adverse medical events, such as uncontrolled bleeding and wrongful deaths, occurred after taking the blood clot prevention drug. Glen Lerner Injury Attorneys announce they now offer free class action claim reviews against drug manufacturers from those who believe they were injured after taking the drug and not properly warned about the increased potential for serious and irreversible bleeding risks due to lack of reversal agent. U.S.A. (PRWEB) September 18,...

2014-09-09 23:01:17

A Class I recall designation by the FDA indicates that use of the recalled medical device may potentially lead to serious adverse reactions or death. Port Washington, New York (PRWEB) September 09, 2014 Parker Waichman LLP, a national law firm that has long been dedicated to protecting the rights of victims who have been injured due to medical devices, comments on a recall issued by DePuy Synthes of its Craniomaxillofacial Distraction System. Federal regulators recently deemed the matter...

2014-09-08 23:06:21

With the release of a recent JAMA Psychiatry study showing that psychiatric drugs send nearly 90,000 Americans to emergency rooms annually, Citizens Commission on Human Rights, the leading mental health watchdog, in its latest article says there is a need for consumers to search its Psychiatric Drug Side Effects Database to learn the documented risks of these drugs. Los Angeles, California (PRWEB) September 08, 2014 A recent JAMA Psychiatry study revealed that between 2009 and 2011, there...

2014-09-08 08:29:52

MISSISSAUGA, ON, Sept. 8, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that it has reached a full settlement with Mallinckrodt Inc. of Nuvo's claims and Mallinckrodt's counterclaim relating to Nuvo's license to Mallinckrodt of the right to market and sell Pennsaid(®) and Pennsaid 2% in the United States. Under the terms of the settlement agreement, Mallinckrodt will return...

2014-09-05 20:21:11

RANDOLPH, N.J., Sept. 5, 2014 /PRNewswire/ -- Pharmacy Creations has voluntarily recalled four product lots (see below) following testing results conducted by Front Range, Inc., its former independent testing laboratory, that indicated that the product lots may have the potential of not being sterile. Pharmacy Creations no longer uses Front Range, Inc. for testing of any kind for any of its formulations. Although we cannot be certain that the product subject to the recall is contaminated,...

2014-08-07 23:11:13

A new study and several lawsuits link Xarelto with uncontrollable bleeding injuries and increased risks of hemorrhage, stroke, pulmonary embolism, and death. Attorneys for Levinson Axelrod are investigating claims that the drug may be too dangerous for patients. Edison, NJ (PRWEB) August 07, 2014 The law firm of Levinson Axelrod is examining new reports that the blood thinner Xarelto, manufactured in Germany by Janssen Pharmaceuticals, Inc., and Bayer AG, may be linked to severe adverse...

2014-08-07 15:44:44

The JAMA Network Journals Researchers have identified genetic variants that are associated with severe adverse skin reactions to the antiepileptic drug phenytoin, according to a study in the August 6 issue of JAMA. Phenytoin is a widely prescribed antiepileptic drug and remains the most frequently used first-line antiepileptic drug in hospitalized patients. Although effective for treating neurological diseases, phenytoin can cause cutaneous (skin) adverse reactions ranging from mild to...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related